BAXTER INTERNATIONAL INC acquires Cheetah Medical, Inc. (Cheetah)
Snapshot
BAXTER INTERNATIONAL INC acquired Cheetah Medical, Inc. (Cheetah) for $188 million total cash consideration net of cash acquired, plus up to $40 million of contingent consideration (acquisition-date fair value $18 million) in October 2019. The transaction was structured as all cash (with contingent consideration). Cheetah Medical, Inc. (Cheetah) is a Newton Center, Massachusetts, USA-based Patient monitoring / hemodynamic monitoring business.
- Acquirer
- BAXTER INTERNATIONAL INC
- Target
- Cheetah Medical, Inc. (Cheetah)
- Value
- $188 million total cash consideration net of cash acquired, plus up to $40 million of contingent consideration (acquisition-date fair value $18 million)
- Date
- October 2019
- Type
- full acquisition
- Status
- ready
The deal at a glance
About this deal
BAXTER INTERNATIONAL INC acquired Cheetah Medical, Inc. (Cheetah) for $188 million total cash consideration net of cash acquired, plus up to $40 million of contingent consideration (acquisition-date fair value $18 million), a transaction completed in October 2019, structured as all cash (with contingent consideration).
Cheetah Medical, Inc. (Cheetah) operates in Patient monitoring / hemodynamic monitoring, is based in Newton Center, Massachusetts, USA. Cheetah Medical is a provider of non-invasive fluid management and hemodynamic monitoring technologies used to guide fluid administration decisions in critical and surgical care.
Adds non-invasive hemodynamic monitoring and fluid management technology that complements Baxter's acute care and critical-care portfolio.
Non-invasive hemodynamic monitoring technology complementary to Baxter's acute and critical-care therapies. Integrated into Baxter's acute care / critical care business
No advisory firms have been disclosed for this transaction.